Skip to main content
. Author manuscript; available in PMC: 2013 Nov 27.
Published in final edited form as: Macromolecules. 2012 Nov 13;45(22):8939–8952. doi: 10.1021/ma301568u

Figure 15.

Figure 15

A) Contrast agent MS-325 that noncovalently binds to serum proteins and forms a macromolecular structure developed by Lauffer and coworkers (marketed as Vasovist and Ablivar). B) NMRD profile of MS-325 (black circles) and MS-325 with water binding site blocked (white circles), both in serum. C) Blood pool image attained with MS-325 in a human subject.84 Figure Adapted with permission from Caravan, P.; Acc. Chem. Res. 2009, 42, 851–62, copyright 2009 American Chemical Society.84